Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
settlement
Pharma
Teva agrees with Axsome to keep generic off market until 2038
The settlement will keep Teva's generic version of Axsome's major depressive disorder drug Auvelity off the market until at least 2038.
Kevin Dunleavy
Feb 10, 2025 11:28am
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Jan 27, 2025 10:39am
Sackler family, Purdue Pharma strike new $7.4B opioid settlement
Jan 24, 2025 8:01am
BioNTech settles with NIH, Penn over COVID vaccine royalties
Jan 3, 2025 10:59am
Sandoz shells out $275M in settlement over price-fixing claims
Dec 17, 2024 11:19am
Consultant McKinsey to pay $650M in federal opioid settlement
Dec 13, 2024 1:58pm
